DE602005024959D1 - Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen - Google Patents

Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen

Info

Publication number
DE602005024959D1
DE602005024959D1 DE602005024959T DE602005024959T DE602005024959D1 DE 602005024959 D1 DE602005024959 D1 DE 602005024959D1 DE 602005024959 T DE602005024959 T DE 602005024959T DE 602005024959 T DE602005024959 T DE 602005024959T DE 602005024959 D1 DE602005024959 D1 DE 602005024959D1
Authority
DE
Germany
Prior art keywords
ointment
pharmaceutical composition
active substances
ingredient active
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024959T
Other languages
English (en)
Inventor
Leslie Zanutto
Sandrine Orsoni
Nathalie Barthez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Publication of DE602005024959D1 publication Critical patent/DE602005024959D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005024959T 2004-06-17 2005-06-15 Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen Active DE602005024959D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0406609A FR2871694B1 (fr) 2004-06-17 2004-06-17 Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
PCT/FR2005/001493 WO2006005842A1 (fr) 2004-06-17 2005-06-15 Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises.

Publications (1)

Publication Number Publication Date
DE602005024959D1 true DE602005024959D1 (de) 2011-01-05

Family

ID=34946515

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024959T Active DE602005024959D1 (de) 2004-06-17 2005-06-15 Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen

Country Status (14)

Country Link
US (1) US20050281848A1 (de)
EP (1) EP1758588B1 (de)
JP (1) JP2008502661A (de)
CN (1) CN101090725A (de)
AT (1) ATE489098T1 (de)
AU (1) AU2005261569A1 (de)
BR (1) BRPI0511206A (de)
CA (1) CA2567680A1 (de)
DE (1) DE602005024959D1 (de)
ES (1) ES2360469T3 (de)
FR (1) FR2871694B1 (de)
MX (1) MXPA06014407A (de)
RU (1) RU2007101516A (de)
WO (1) WO2006005842A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885527B1 (fr) * 2005-05-16 2007-06-29 Galderma Res & Dev Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
RU2452488C2 (ru) * 2006-08-29 2012-06-10 Тева Фармасьютикал Индастриес Лтд. Фармацевтические композиции, содержащие витамин группы d и кортикостероид
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
FR2912655A1 (fr) * 2007-02-15 2008-08-22 Galderma Sa Produit de soin cutane a double compartiment comprenant du calcitriol et du propionate de clobetasol, et son utilisation
EP1970048A1 (de) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topische Zusammensetzung mit Vitamin D
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
US20120004200A1 (en) * 2008-12-23 2012-01-05 Galderma S.A. Topical pharmaceutical composition containing a water-sensitive active principle
US20120322776A1 (en) * 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
ES2452872T3 (es) * 2009-12-22 2014-04-03 Leo Pharma A/S Composición farmacéutica que comprende una mezcla solvente y un derivado o análogo de vitamina D
BR112013023458B1 (pt) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd composição oftálmica, e, método para fabricar a composição oftálmica
CN104666312B (zh) * 2015-02-12 2017-11-07 重庆华邦制药有限公司 含有卡泊三醇和二丙酸倍他米松的制剂
CN108969527B (zh) * 2017-05-31 2021-05-11 上海通用药业股份有限公司 一种药物制剂及其制备方法和用途
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
DK2450043T3 (en) * 1999-04-23 2016-09-12 Leo Pharma As A pharmaceutical composition for use on skin for the treatment of psoriasis comprising calcipotriol and betamethasone
BRPI0114927B8 (pt) * 2000-10-27 2021-05-25 Leo Pharma As composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
RU2361594C2 (ru) * 2002-12-17 2009-07-20 Галдерма Са Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат
US7582307B2 (en) * 2003-11-26 2009-09-01 Harmony Labs, Inc. Dermatological composition

Also Published As

Publication number Publication date
BRPI0511206A (pt) 2007-11-27
AU2005261569A1 (en) 2006-01-19
CN101090725A (zh) 2007-12-19
ATE489098T1 (de) 2010-12-15
EP1758588B1 (de) 2010-11-24
CA2567680A1 (fr) 2006-01-19
MXPA06014407A (es) 2007-02-19
US20050281848A1 (en) 2005-12-22
ES2360469T3 (es) 2011-06-06
WO2006005842A1 (fr) 2006-01-19
JP2008502661A (ja) 2008-01-31
RU2007101516A (ru) 2008-07-27
EP1758588A1 (de) 2007-03-07
FR2871694B1 (fr) 2008-07-04
FR2871694A1 (fr) 2005-12-23

Similar Documents

Publication Publication Date Title
DE602005024959D1 (de) Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen
ECSP099387A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BRPI0307550B8 (pt) composição farmacêutica em gel tópica, de adapaleno 0,3%
NO20062198L (no) Bradykinin B1 reseptorantagonister
ZA200501715B (en) Solution for ungual application
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
BRPI0612125A2 (pt) compostos da fórmula (i), processo para a fabricação destes, composto da fórmula iiia, composições farmacêuticas, método para o tratamento e/ou profilaxia de doenças associadas à modulação dos receptores cb1 e uso de compostos
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
BRPI0511420A (pt) fosforodiamidatos de sulfoniletila
EA200702594A1 (ru) Многофункциональные композиции концентрата с высоким содержанием действующего вещества для контроля эктопаразитов
FR2887150B1 (fr) Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
ATE414092T1 (de) Phosphoindole als hiv-inhibitoren
DK1492773T3 (da) 4-(Heterocyclyl)-benzensulfoximin-forbindelser til behandling af inflammation
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
WO2005117871A3 (en) Pharmaceutical compositions for the treatment of pruritus
AR000357A1 (es) Utilización de un antagonista de sustancia p para la preparación de una composición farmacéutica de aplicación topica para tratar las manchas rojas cutaneas de origen neurogeno y especialmente la rosacea y el eritema pudico
ITMI20052515A1 (it) Formulazione farmaceutica per il trattamento della osteoartrite
DE60316724D1 (de) Pharmazeutische zusammensetzung enthaltend calcitriol und clobetasol propionate
UY26473A1 (es) Compuestos activos en el receptor de glucocorticoide
DE602004017164D1 (de) Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten
ES2187446T3 (es) Composicion para el tratamiento de la psoriasis.
EE04952B1 (et) Ravimkoostis ja meetod selle valmistamiseks